Annie Oh, MD

Title(s)CLINICAL FELLOW, Medicine
SchoolSchool of Medicine
Address505 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. PARP Inhibition Synergizes with Melphalan but Does not Reverse Resistance Completely. Biol Blood Marrow Transplant. 2020 07; 26(7):1273-1279. Patel PR, Senyuk V, Sweiss K, Calip GS, Pan D, Rodriguez N, Oh A, Mahmud N, Rondelli D. PMID: 32194286.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Superior Survival in African American Patients Who Underwent Autologous Stem Cell Transplantation for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2019 08; 19(8):e506-e511. Sweiss K, Oh A, Calip GS, Rondelli D, Patel P. PMID: 31231013.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. Synergistic Cytotoxic Effect of Busulfan and the PARP Inhibitor Veliparib in Myeloproliferative Neoplasms. Biol Blood Marrow Transplant. 2019 05; 25(5):855-860. Patel PR, Senyuk V, Rodriguez NS, Oh AL, Bonetti E, Mahmud D, Barosi G, Mahmud N, Rondelli D. PMID: 30615982.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    4. Renal dysfunction within 90 days of FluBu4 predicts early and late mortality. Bone Marrow Transplant. 2019 07; 54(7):980-986. Sweiss K, Calip GS, Oh AL, Rondelli D, Patel PR. PMID: 30604772.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    5. Similar survival but increased toxicity with a sequential versus concurrent FluBu4 regimen. Bone Marrow Transplant. 2018 09; 53(9):1221-1224. Sweiss K, Oh A, Calip G, Rondelli D, Patel P. PMID: 29703968.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    6. Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease. Biol Blood Marrow Transplant. 2018 08; 24(8):1759-1765. Saraf SL, Oh AL, Patel PR, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Jain S, Peace D, Quigley JG, Khan I, Molokie RE, Mahmud N, Gordeuk VR, Rondelli D. PMID: 29656137.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    7. A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo. Cancer Res. 2018 03 15; 78(6):1549-1560. Nguyen HA, Su Y, Zhang JY, Antanasijevic A, Caffrey M, Schalk AM, Liu L, Rondelli D, Oh A, Mahmud DL, Bosland MC, Kajdacsy-Balla A, Peirs S, Lammens T, Mondelaers V, De Moerloose B, Goossens S, Schlicht MJ, Kabirov KK, Lyubimov AV, Merrill BJ, Saunthararajah Y, Van Vlierberghe P, Lavie A. PMID: 29343523.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    8. A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant. Bone Marrow Transplant. 2018 03; 53(3):300-306. Sweiss K, Anderson J, Wirth S, Oh A, Quigley JG, Khan I, Saraf S, Mactal-Haaf C, Rondelli D, Patel P. PMID: 29269796.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCTClinical Trials
    9. A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Leuk Lymphoma. 2018 07; 59(7):1666-1671. Patel P, Oh AL, Koshy M, Sweiss K, Saraf SL, Quigley JG, Khan I, Mahmud N, Hacker E, Ozer H, Peace DJ, Weichselbaum RR, Aydogan B, Rondelli D. PMID: 29065747.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    10. A novel drug interaction between busulfan and blinatumomab. J Oncol Pharm Pract. 2019 Jan; 25(1):226-228. Sweiss K, Quigley JG, Oh A, Lee J, Ye R, Rondelli D, Patel P. PMID: 28857712.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. T Cell-Mediated Rejection of Human CD34+ Cells Is Prevented by Costimulatory Blockade in a Xenograft Model. Biol Blood Marrow Transplant. 2017 Dec; 23(12):2048-2056. Oh AL, Mahmud D, Nicolini B, Mahmud N, Senyuk V, Patel PR, Bonetti E, Arpinati M, Ferrara JLM, Rondelli D. PMID: 28818684.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    12. Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation. Case Rep Infect Dis. 2016; 2016:3242196. Sweiss K, Oh A, Rondelli D, Patel P. PMID: 27403356.
      View in: PubMed   Mentions:
    13. Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. Biol Blood Marrow Transplant. 2016 Mar; 22(3):441-8. Saraf SL, Oh AL, Patel PR, Jalundhwala Y, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Hassan J, Peace D, Quigley JG, Khan I, Molokie RE, Hsu LL, Mahmud N, Levinson DJ, Pickard AS, Garcia JG, Gordeuk VR, Rondelli D. PMID: 26348889.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    14. Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study. Biol Blood Marrow Transplant. 2014 Dec; 20(12):2034-41. Patel P, Aydogan B, Koshy M, Mahmud D, Oh A, Saraf SL, Quigley JG, Khan I, Sweiss K, Mahmud N, Peace DJ, DeMasi V, Awan AM, Weichselbaum RR, Rondelli D. PMID: 25234438.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    Annie's Networks
    Concepts (93)
    Derived automatically from this person's publications.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department